【私のイチオシ!】RSNA2011注目の演題:堀越浩幸先生(群馬県立がんセンター)

【私のイチオシ!】コーナーでは、先生方が注目する面白そうなセッションや口演・ポスター発表等についてご紹介します。

2011.11.21

堀越浩幸先生(群馬県立がんセンター放射線診断部)が注目するセッションはこちらです!

CODE: MSVO11-06
SESSION: Interventional Oncology Series: Hepatocellular Carcinoma (An Interactive Session)
Transarterial Chemoembolization of Unresectable Hepatocellular Carcinoma (HCC): Drug-eluting-Bead Embolization (DEB-TACE) vs Conventional TACE with Cisplatin / Lipiodol (cTACE)
Philipp Wiggermann et al

DATE: Sunday, November 27 2011
TIME: 03:00 PM – 03:10 PM
LOCATION: S405AB
●PURPOSE
Outcome evaluation of DEB-TACE compared to cTACE in patients with unresectable HCC.

CODE: MSVM21-16
SESSION: Breast/Nuclear Medicine/Molecular Imaging Series: Breast Imaging in the Era of Molecular Medicine
Multimodal Multiparametric PET-MRI in the Assessment of Breast Lesions
Katja Pinker MD et al

DATE: Monday, November 28 2011
TIME: 11:40 AM – 11:50 AM
LOCATION: Arie Crown Theater
●PURPOSE
To demonstrate the feasibility of multimodal multiparametric PET-MRI in the assessment of breast tumors.

CODE: SSA01-02
SESSION: ISP: Breast Imaging (Ultrasound)
Probably Benign Lesions on Screening Breast Sonography: Prevalence and Risk of Malignancy in the ACRIN 6666 Trial
Richard Barr MD, PhD et al

DATE: Sunday, November 27 2011
TIME: 10:55 AM – 11:05 AM
LOCATION: Arie Crown Theater
●PURPOSE
To determine the prevalence and malignancy rate of BI-RADS 3 (B3) ultrasound (US) lesions in the ACRIN 6666 study.

CODE: SSE01-05
SESSION: Breast Imaging (MR Image Interpretation I)
Bilateral Preoperative MR Examinations in Newly Diagnosed Breast Cancer Patients: Initial and Long-term Impact on Contralateral Breast Cancer Diagnosis
Jin You Kim MD et al

DATE: Monday, November 28 2011
TIME: 03:40 PM – 03:50 PM
LOCATION: Arie Crown Theater
●PURPOSE
Breast MRI can detect contralateral cancers missed by mammography and physical examination. However, controversy remains over the clinical efficacy of preoperative MRI. Thus, we assessed whether bilateral preoperative MRI could reduce contralateral breast recurrence at long- term follow-up(FU).

CODE: SSE01-06
SESSION: Breast Imaging (MR Image Interpretation I)
Utility of Preoperative Breast MRI in Women ≤ 40 Years Old
Janice Sung MD et al

DATE: Monday, November 28 2011
TIME: 03:50 PM – 04:00 PM
LOCATION: Arie Crown Theater
●PURPOSE
To determine the prevalence and risk factors of additional mammographically occult breast cancers detected on preoperative breast MRI in women ≤ 40 years old.

CODE: SSE06-06
SESSION: ISP: Gastrointestinal (Ablation Technique: GI)
The Role of Pretreatment Diffusion-weighted MR Imaging in Predicting Long-term Outcome of Colorectal Liver Metastasis
Henry Tam MBBS et al

DATE: Monday, November 28 2011
TIME: 03:50 PM – 04:00 PM
LOCATION: E353A
●PURPOSE
To determine the prognostic value of pretreatment ADC of colorectal liver metastases in predicting disease response, progression free survival (PFS) and overall survival (OS).

CODE: SSM02-04
SESSION: Breast Imaging (MR Image Interpretation III)
The Molecular Subtypes of Pure Ductal Carcinoma in Situ: Correlation with MR Imaging and Pathologic Findings
Min Sun Bae et al

DATE: Wednesday, November 30 2011
TIME: 03:30 PM – 03:40 PM
LOCATION: E450A
●PURPOSE
To retrospectively evaluate the MRI and pathologic findings of pure ductal carcinoma in situ (DCIS) lesions according to molecular subtypes.

CODE: LL-BRS-SU1A
SESSION: Breast Imaging
Evaluation of Stereoscopic 3D Digital Mammography on Lesion Assessment and Confidence Levels: A Preliminary Study
James Reza Fernandez MD, MS et al

DATE: Sunday, November 27 2011
TIME: 12:30 PM – 01:00 PM
LOCATION: Lakeside Learning Center
●PURPOSE
Compare lesion assessment and confidence levels of 2D Full-field digital mammography (FFDM) with stereoscopic 3-Dimensional digital mammography (3D DM) and evaluate the potential application of this technology for screening and diagnostic mammography.

CODE: LL-BRS-TU3A
SESSION: Breast Imaging
Characterization of Breast Lesions: Diffusion-weighted (DW) Imaging with Consideration of Apparent Diffusion Coefficient (ADC) vs Dynamic-enhanced 3.0 T MR Imaging
injae Yoon et al

DATE: Tuesday, November 29 2011
TIME: 12:15 PM – 12:45 PM
LOCATION: Lakeside Learning Center
●PURPOSE
To compare the accuracy of DWI with consideration of ADC with that of dynamic enhanced MRI for the characterization of breast lesions

CODE: SSM02-04
SESSION: Breast Imaging (MR Image Interpretation III)
The Molecular Subtypes of Pure Ductal Carcinoma in Situ: Correlation with MR Imaging and Pathologic Findings
Min Sun Bae et al

DATE: Wednesday, November 30 2011
TIME: 03:30 PM – 03:40 PM
LOCATION: E450A
●PURPOSE
To retrospectively evaluate the MRI and pathologic findings of pure ductal carcinoma in situ (DCIS) lesions according to molecular subtypes.

CODE: LL-BRS-TH6A
SESSION: Breast Imaging
Diffusion-weighted MRI of Breast Lesions at 3 Tesla: Readout-segmented EPI with Improved Image Quality
Wolfgang Bogner MSC et al

DATE: Thursday, December 01 2011
TIME: 12:15 PM – 12:45 PM
LOCATION: Lakeside Learning Center
●PURPOSE
To qualitatively and quantitatively compare the diagnostic value of diffusion weighted images (DWI) based on standard single-shot echo planar imaging (ss-EPI) and readout-segmented EPI (rs-EPI) in breast cancer patients at 3T.

CODE: LL-GUS-SU1B
SESSION: Genitourinary
Clinical Feasibility of Long-TE DWI in Differentiating Uterine Leiomyoma from Leiomyosarcoma
Ayako Tamura MD et al

DATE: Sunday, November 27 2011
TIME: 01:00 PM – 01:30 PM
LOCATION: Lakeside Learning Center
●PURPOSE
Preoperative diagnosis of leiomyosarcomas on the MRI is still challenging even using some reported criteria suggesting leiomyosarcoma, because uterine leiomyoma sometimes mimics leiomyosarcoma due to its histological variations or various degrees of degeneration. The purpose of this study is to see the clinical usefulness of diffusion-weighted imaging with long TE (TE=200msec) to differentiate between leiomyomas and leiomyosarcomas.

CODE: LL-GIE2792
Preoperative Staging of Colorectal Cancer with Whole Abdominal Fusion Imaging between Diffusion-weighted Imaging and 3D Fat-suppressed Contrast-enhanced T1-weighted Imaging (FDWI) at 3 T and 1.5 T
Hiroyuki Horikoshi MD et al

LUNCHTIME CME:
EXHIBIT HOURS: Sun. 8:00 AM – 6:00 PM
Mon. – Thurs. 7:00 AM – 10:00 PM
Fri. 7:00 AM – 12:45 PM
LOCATION: Lakeside Learning Center
●SUMMARY
This exhibit will provide a basic understanding of preoperative staging of colorectal cancers using the whole-abdominal fusion imaging between diffusion-weighted imaging and 3D fat suppressed contrast-enhanced T1-weighted imaging (FDWI) at 3T and 1.5T. The major teaching points of this exhibit are: 1. The whole-abdominal FDWI at 3T and 1.5T is a useful method for detection of colorectal cancers and liver metastases. 2. The FDWI is a novel technique for preoperative staging of colorectal cancers.

このページの先頭へ戻る